Expression of E-cadherin transcriptional regulators in ovarian carcinoma

被引:95
|
作者
Elloul, Sivan
Silins, Ilvars
Trope, Claes G.
Benshushan, Avi
Davidson, Ben [1 ]
Reich, Reuven
机构
[1] Univ Oslo, Natl Hosp, Norwegian Radium Hosp, Dept Pathol, N-0310 Oslo, Norway
[2] Hebrew Univ Jerusalem, Hadassah Med Ctr, Dept Obstet & Gynecol, IL-91120 Jerusalem, Israel
[3] Univ Oslo, Natl Hosp, Norwegian Radium Hosp, Dept Gynecol Oncol, N-0310 Oslo, Norway
[4] Hebrew Univ Jerusalem, Sch Pharm, Fac Med, Dept Pharmacol & Expt Therapeut, IL-91120 Jerusalem, Israel
关键词
ovarian carcinoma; E-cadherin; transcriptional repressors;
D O I
10.1007/s00428-006-0274-6
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Unlike most epithelial cancers, E-cadherin expression is upregulated in ovarian carcinoma effusions compared with corresponding primary tumors. In the present study, we analyzed the anatomic site-specific expression of transcription factors that negatively regulate E-cadherin in ovarian carcinoma. Using reverse-transcription polymerase chain reaction, mRNA in situ hybridization, and Western blotting, we analyzed the expression and localization of the Snail, Slug, and SIP1 transcription factors and E-cadherin in 78 effusions, 41 primary carcinomas, and 15 solid metastases. Slug mRNA and protein expression was highest in metastases (p=0.042 and p < 0.001, respectively). Snail mRNA was comparable at all anatomic sites, but higher protein expression was found in primary tumors and solid metastases compared with effusions (p < 0.001). SIP1 mRNA expression was higher in effusions (p < 0.001) compared to other sites. Confocal microscopy analysis of fresh and cultured cells from effusion specimens revealed cytoplasmic localization of the Snail protein in primary tumor cells, with a nuclear shift following culturing of these cells. In conclusion, E-cadherin and its negative regulators show site-dependent expression in ovarian carcinoma. In solid tumors, E-cadherin is negatively regulated by Snail and Slug. In effusions, SIP1 may be the main regulator of E-cadherin, but with a lesser level of suppression compared with primary tumors and solid metastases.
引用
收藏
页码:520 / 528
页数:9
相关论文
共 50 条
  • [1] Expression of E-cadherin transcriptional regulators in ovarian carcinoma
    Sivan Elloul
    Ilvars Silins
    Claes G. Tropé
    Avi Benshushan
    Ben Davidson
    Reuven Reich
    Virchows Archiv, 2006, 449 : 520 - 528
  • [2] E-cadherin expression in ovarian carcinoma
    Nature Clinical Practice Oncology, 2005, 2 (1): : 6 - 6
  • [3] Altered expression of β-catenin, E-cadherin, and E-cadherin promoter methylation in epithelial ovarian carcinoma
    Bhagat, Rahul
    Premalata, C. S.
    Shilpa, V.
    Pallavi, V. R.
    Ramesh, G.
    Vijay, C. R.
    Krishnamoorthy, Lakshmi
    TUMOR BIOLOGY, 2013, 34 (04) : 2459 - 2468
  • [4] E-cadherin complex protein expression and survival in ovarian carcinoma
    Davidson, B
    Gotlieb, WH
    Ben-Baruch, G
    Nesland, JM
    Bryne, M
    Goldberg, I
    Kopolovic, J
    Berner, A
    GYNECOLOGIC ONCOLOGY, 2000, 79 (03) : 362 - 371
  • [5] Expression of E-cadherin and β-catenin in primary and peritoneal metastatic ovarian carcinoma
    Fujioka, T
    Takebayashi, Y
    Kihana, T
    Kusanagi, Y
    Hamada, K
    Ochi, H
    Uchida, T
    Fukumoto, M
    Ito, M
    ONCOLOGY REPORTS, 2001, 8 (02) : 249 - 255
  • [6] Epigenetic regulation of E-cadherin in ovarian carcinoma
    Elloul, Sivan
    Silins, Ilvars
    Trope, Claes G.
    Benshushan, Avi
    Davidson, Ben
    Reich, Reuven
    CANCER RESEARCH, 2006, 66 (08)
  • [7] The role of E-cadherin expression and E-cadherin gene promoter hypermethylation in gastric carcinoma
    Hamed, Mohamed K. F.
    Fawzy, Gamal
    Hanna, Hanna H.
    EGYPTIAN JOURNAL OF SURGERY, 2019, 38 (02): : 361 - 368
  • [8] E-cadherin expression in high grade serous ovarian carcinoma clinicopathological study
    Kostadinova-Kunovska, S.
    Petrushevska, G.
    Jovanovic, R.
    Janevska, V.
    Aluloski, I.
    Tanturovski, M.
    Veljanovska, S.
    VIRCHOWS ARCHIV, 2018, 473 : S79 - S79
  • [9] E-cadherin and β-catenin expression in urothelial carcinoma
    Nikolaidou, A.
    Moisidis, I.
    Koumpanaki, M.
    Dimitriadis, I.
    Anestakis, D.
    Patakiouta, F.
    HISTOPATHOLOGY, 2008, 53 : 282 - 283
  • [10] Expression of E-cadherin in papillary thyroid carcinoma
    Bich, T.
    Nerovnya, A.
    Cherstvoy, E.
    VIRCHOWS ARCHIV, 2009, 455 : 381 - 381